Funding

Latest News

February 14th 2025
Q&A: Gain Therapeutics CEO Discusses AI-Driven Drug Discovery, Strategic Growth Plans

Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial intelligence in the drug discovery process.

February 13th 2025

Latent Labs Launches Publicly with $50 Million in Funding for Artificial Intelligence-Powered Programmable Biology

February 12th 2025

Abcuro Secures $200 Million in Series C Funding to Advance Ulviprubart for Inclusion Body Myositis

Subin Baral
January 20th 2025

The Present and Future of M&A: Q&A with Subin Baral